<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kassaar O</submitter><funding>British Heart Foundation</funding><funding>Biotechnology and Biological Sciences Research Council</funding><pagination>101-10</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4309485</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Histidine-rich glycoprotein (HRG) regulates coagulation through its ability to bind and neutralize heparins. HRG associates with Zn(2+) to stimulate HRG-heparin complex formation. Under normal conditions, the majority of plasma Zn(2+) associates with human serum albumin (HSA). However, free fatty acids (FFAs) allosterically disrupt Zn(2+) binding to HSA. Thus, high levels of circulating FFAs, as are associated with diabetes, obesity, and cancer, may increase the proportion of plasma Zn(2+) associated with HRG, contributing to an increased risk of thrombotic disease.&lt;h4>Objectives&lt;/h4>To characterize Zn(2+) binding by HRG, examine the influence that FFAs have on Zn(2+) binding by HSA, and establish whether FFA-mediated displacement of Zn(2+) from HSA may influence HRG-heparin complex formation.&lt;h4>Methods&lt;/h4>Zn(2+) binding to HRG and to HSA in the presence of different FFA (myristate) concentrations were examined by isothermal titration calorimetry (ITC) and the formation of HRG-heparin complexes in the presence of different Zn(2+) concentrations by both ITC and ELISA.&lt;h4>Results and conclusions&lt;/h4>We found that HRG possesses 10 Zn(2+) sites (K' = 1.63 × 10(5) ) and that cumulative binding of FFA to HSA perturbed its ability to bind Zn(2+) . Also Zn(2+) binding was shown to increase the affinity with which HRG interacts with unfractionated heparins, but had no effect on its interaction with low molecular weight heparin (~ 6850 Da). [Correction added on 1 December 2014, after first online publication: In the preceding sentence, "6850 kDa" was corrected to "6850 Da".] Speciation modeling of plasma Zn(2+) based on the data obtained suggests that FFA-mediated displacement of Zn(2+) from serum albumin would be likely to contribute to the development of thrombotic complications in individuals with high plasma FFA levels.</pubmed_abstract><journal>Journal of thrombosis and haemostasis : JTH</journal><pubmed_title>Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin.</pubmed_title><pmcid>PMC4309485</pmcid><funding_grant_id>FS/10/036/28352</funding_grant_id><funding_grant_id>FS/10/36/28352</funding_grant_id><funding_grant_id>BB/J006467/1</funding_grant_id><pubmed_authors>Schwarz-Linek U</pubmed_authors><pubmed_authors>Blindauer CA</pubmed_authors><pubmed_authors>Kassaar O</pubmed_authors><pubmed_authors>Stewart AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin.</name><description>&lt;h4>Background&lt;/h4>Histidine-rich glycoprotein (HRG) regulates coagulation through its ability to bind and neutralize heparins. HRG associates with Zn(2+) to stimulate HRG-heparin complex formation. Under normal conditions, the majority of plasma Zn(2+) associates with human serum albumin (HSA). However, free fatty acids (FFAs) allosterically disrupt Zn(2+) binding to HSA. Thus, high levels of circulating FFAs, as are associated with diabetes, obesity, and cancer, may increase the proportion of plasma Zn(2+) associated with HRG, contributing to an increased risk of thrombotic disease.&lt;h4>Objectives&lt;/h4>To characterize Zn(2+) binding by HRG, examine the influence that FFAs have on Zn(2+) binding by HSA, and establish whether FFA-mediated displacement of Zn(2+) from HSA may influence HRG-heparin complex formation.&lt;h4>Methods&lt;/h4>Zn(2+) binding to HRG and to HSA in the presence of different FFA (myristate) concentrations were examined by isothermal titration calorimetry (ITC) and the formation of HRG-heparin complexes in the presence of different Zn(2+) concentrations by both ITC and ELISA.&lt;h4>Results and conclusions&lt;/h4>We found that HRG possesses 10 Zn(2+) sites (K' = 1.63 × 10(5) ) and that cumulative binding of FFA to HSA perturbed its ability to bind Zn(2+) . Also Zn(2+) binding was shown to increase the affinity with which HRG interacts with unfractionated heparins, but had no effect on its interaction with low molecular weight heparin (~ 6850 Da). [Correction added on 1 December 2014, after first online publication: In the preceding sentence, "6850 kDa" was corrected to "6850 Da".] Speciation modeling of plasma Zn(2+) based on the data obtained suggests that FFA-mediated displacement of Zn(2+) from serum albumin would be likely to contribute to the development of thrombotic complications in individuals with high plasma FFA levels.</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Jan</publication><modification>2024-11-21T02:42:52.259Z</modification><creation>2019-03-27T01:44:11Z</creation></dates><accession>S-EPMC4309485</accession><cross_references><pubmed>25353308</pubmed><doi>10.1111/jth.12771</doi></cross_references></HashMap>